Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Acute pancreatitis (AP), one of the most common clinical emergencies, is characterized by variable clinical features and inadequate diagnostic methods. At present, the commonly used indicators do not have high specificity and do not necessarily reflect disease severity. We therefore aimed to investigate diagnostic and prognostic value of plasma procalcitonin, heparin-binding protein, and interleukin-6 for acute pancreatitis by separate detection and joint detection.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>The study involved 451 participants, including 343 AP patients and 108 healthy controls. We analyzed the association of the three biomarkers with the severity and prognosis of AP.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>A statistically significant increase in the mean plasma analyte levels was detected in the study group compared to the control group. Multivariate comparison showed that plasma levels of PCT, HBP, and IL-6 were all significantly different among the three groups at different sampling times (1st, 3rd, 7th, and 10th day of admission) (<i>p</i> < 0.01). The combination of the three indicators had significantly higher diagnostic value than either the individual markers or pairwise combinations (<i>p</i> < 0.001). The levels of the three were all significantly higher in severe acute pancreatitis (SAP) patients than in non-SAP patients (<i>p</i> < 0.001); meanwhile, patients with high levels had a worse prognosis than those with low levels (<i>p</i> < 0.05). In multivariate analysis adjusted for age and sex, high levels of PCT, HBP, and IL-6 were found to be independently associated with the development of AP. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>It dramatically improved the diagnostic power of AP when PCT, HBP, and IL-6 were combined; high PCT, HBP, and IL-6 levels within 3 days of admission may be the potentially useful indicators for predicting SAP.</p></section>

The clinical value of plasma microRNA-216 for early identifying the severity of acute pancreatitis

Circulating Microrna 216 As a Marker for the Early Identification of Severe Acute Pancreatitis.

Serum Micrornas As Novel Biomarkers for Early Prediction of Disease Severity in Patients with Acute Pancreatitis

Combination of Plasma Micrornas with Serum Ca19-9 for Early Detection of Pancreatic Cancer

Identification of serum microRNAs as diagnostic and prognostic biomarkers for acute pancreatitis.

Quantitative Analysis of Circulating DNA in Plasma of Patients with Acute Pancreatitis and Its Potential Clinical Value

Differential expression of plasma exosomal microRNA in severe acute pancreatitis

Circulating MicroRNA Panel As a Diagnostic Marker for Hepatocellular Carcinoma

Circulating Mirnas As Biomarkers for Severe Acute Pancreatitis Associated with Acute Lung Injury.

The Decreased PKM2 Contributes to the Survival of Pancreatic Cancer Cells in Hypoglucose by Promoting Autophagy

Comparison of MPL-ANN and PLS-DA models for predicting the severity of patients with acute pancreatitis: An exploratory study

Elevated Serum Mir-7, Mir-9, Mir-122, and Mir-141 Are Noninvasive Biomarkers of Acute Pancreatitis

Role of C Reactive Protein Combined with Hematocrit in Early Prediction of Severe Acute Pancreatitis

Testing and Its Clinical Significance of Plasma Neutrophil Gelatinase-Associated Lipocalin in Patients with Acute Pancreatitis

Plasma Mirnas Effectively Distinguish Patients With Pancreatic Cancer From Controls A Multicenter Study

Plasma Microrna Panels To Diagnose Pancreatic Cancer: Results From A Multicenter Study

Combined detection of procalcitonin, heparin‐binding protein, and interleukin‐6 is a promising assay to diagnose and predict acute pancreatitis

The diagnostic value of serum C-reactive protein, procalcitonin, interleukin-6 and lactate dehydrogenase in patients with severe acute pancreatitis

Plasma Cytokines Can Help to Identify the Development of Severe Acute Pancreatitis on Admission

The clinical value of dynamic monitoring of serum heparin binding protein, procalcitonin and IL-18 in evaluating the severity of acute pancreatitis

Clinical predictive value of control attenuation parameters in combination with miR-192-5p in patients with acute pancreatitis in nonalcoholic fatty liver disease